4//SEC Filing
Loose Christopher R. 4
Accession 0001127602-23-020997
CIK 0001703647other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:13 PM ET
Size
7.0 KB
Accession
0001127602-23-020997
Insider Transaction Report
Form 4
Loose Christopher R.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-17$0.67/sh−1,415$948→ 196,037 total - Sale
Common Stock
2023-07-18$0.56/sh−1,484$831→ 194,553 total
Footnotes (3)
- [F1]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.60 to $0.71. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.55 to $0.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001785299
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:13 PM ET
- Size
- 7.0 KB